novo nordisk glp 1 drugs FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by and Eli Lilly Novo, Lilly weight-loss drugs should

Contraindications:: Patients with a personal or family history of medullary thyroid carcinoma (based upon animal data - see FDA Warning) History of hypersensitivity to semaglutide or any of its excipients (serious reactions including angioedema & anaphylaxis have been reported) Side Effects: GI Adverse events: nausea, vomiting, constipation, diarrhea (~5-15%) most GI side side effects occur during dose initiation or escalation and wane after a few weeks (Drucker, 2024)

What are the considerations for intravenous B12 dosing

164 KeF

Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024